On Tuesday, Shares of Frontier Communications Corp (NASDAQ:FTR), lost -1.60% to $4.68.
Frontier Communications declared its Vice President and Treasurer, John Gianukakis, is planned to present at the Deutsche Bank 2015 Leveraged Finance Conference in Scottsdale, Arizona on Tuesday, September 29, 2015 at 11:40 a.m. Eastern.
Frontier Communications Corporation is a communications company. The Company is engaged in providing services to rural areas and small and medium-sized towns and cities in the United States. It offers a range of voice, data and video services and products.
Shares of Northstar Realty Finance Corp (NYSE:NRF), declined -3.82% to $11.82, during its last trading session.
Northstar Realty Finance declared that its Board of Directors has authorized the repurchase of up to $500 million of its outstanding common stock.
The repurchases will occur from time to time in the open market and/or in privately negotiated transactions as market conditions permit. The authorization will expire in 12 months, unless otherwise extended by NorthStar Realty’s Board of Directors. The repurchase program will be utilized at administration’s discretion and in accordance with the requirements of the Securities and Exchange Commission. The timing and actual number of shares repurchased will depend on a variety of factors counting price, corporate requirements and other conditions.
NorthStar Realty Finance Corp. is a commercial real estate company. The Company invests in multiple asset classes across commercial real estate (CRE). Its portfolio consists of healthcare, hotel, manufactured housing communities, net lease, multifamily properties and international real estate, with a focus on Europe.
Shares of Procter & Gamble Co (NYSE:PG), inclined 0.79% to $72.34, during its last trading session.
Award-winning producer Mark Burnett will return as executive producer of PEOPLE’S CHOICE AWARDS 2016, which will broadcast live from the Microsoft Theater in Los Angeles Wednesday, Jan. 6, 2016 (9:00-11:00 PM, live ET/delayed PT) on the CBS Television Network. PEOPLE’S CHOICE AWARDS 2016 will serve as the kick-off to the 2016 awards show season.
The People’s Choice Awards is the only major awards show where fans choose the nominees and winners across multiple genres of movies, music and television. Metro-Goldwyn-Mayer (MGM) will distribute the show internationally. Voting to determine the nominees starts Tuesday, October 13, 2015 (10:00 AM, ET) at www.PeoplesChoice.com through Thursday, October 22, 2015 (11:59 PM, ET). The nominations declaration press conference, to be held on Tuesday, November 3, 2015 at the Paley Center for Media in Beverly Hills, will reveal the final nominees in all categories and launch the second phase of voting on the website and social platforms. Voting to determine the winners will remain open until Thursday, December 3, 2015. Voting for the Favorite New TV Comedy and Drama categories will start Friday, December 4, 2015 and run throughout the first hour of PEOPLE’S CHOICE AWARDS 2016 on January 6.
The Procter & Gamble Company (P&G) provides consumer packaged goods. The Company operates in five segments under GBUs: Beauty, which offers a range of products ranging from deodorants to cosmetics to skin care; Grooming, which includes blades, razors and electronic hair removal devices, such as electric razors and epilators; Health Care, which includes oral care and personal health care products.; Fabric Care and Home Care, which consists of a range of fabric care products, home care products and batteries, and Baby Feminine and Family Care, which offers diapers, pants, baby wipe, Bounty paper, towel and Charmin toilet paper brands.
Finally, Endo International, (NASDAQ:ENDP), ended its last trade with -2.02% loss, and closed at $60.57.
Endo International declared it has accomplished its formerly declared $8.05 billion acquisition of Par Pharmaceutical Holdings, Inc. from leading global private investment firm TPG.
Through this acquisition, Endo has further established its position as a leading global specialty pharmaceutical company with a fast growing generics business that is among the top five as measured by U.S. sales according to IMS. The acquisition also assists position Endo for long-term double-digit organic growth, improved cash flow generation and raised financial flexibility. Endo’s generics portfolio now comprises an extensive range of in market and R&D stage complex and competitively differentiated dosage forms and delivery systems, with a focus on higher barrier-to-entry and first-to-market products. Endo’s combined U.S. Generics segment, which comprises Par Pharmaceutical and Qualitest, will be named Par Pharmaceutical, an Endo International Company and will be led by Paul Campanelli , former Chief Executive Officer of Par Pharmaceutical, who will also join Endo’s Executive Leadership Team.
In accordance with the terms of the merger agreement, the purchase price comprises of about 18 million shares of Endo equity and $6.50 billion in cash consideration to former Par shareholders. The transaction was financed by a combination of cash, debt and proceeds from a $2.3 billion equity offering accomplished in June 2015 .
The closing of the transaction follows the unanimous vote of the Federal Trade Commission on September 24, 2015 to approve a consent order in connection with the transaction. Under the consent order, Endo has agreed to divest its glycopyrrolate and methimazole products to Rising Pharmaceuticals Inc.
Endo International plc, a specialty healthcare company, focuses on branded and generic pharmaceuticals and devices worldwide. It operates through four segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals, Devices, and International Pharmaceuticals. The U.S. Branded Pharmaceuticals segment provides various branded prescription products, including Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Fortesta Gel, Supprelin LA, Valstar, Vantas, Sumavel DosePro, Aveed, and Natesto to treat and manage pain and conditions in urology, endocrinology, and oncology.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
